RECCE 327 Urinary Tract Infection (UTI) Treatment

Aug 12
4 min read

Uncomplicated UTI CRISPR-Cas3 Treatment Shows Positive Results

LBP-EC01 is a CRISPR-Cas3 genetically engineered bacteriophage therapy designed to treat patients with uncomplicated urinary tract infections caused by antimicrobial-resistant and multi-drug-resistant Escherichia coli
UTI
Urinary Track Infection (UTI)
Jun 11
4 min read

Innovative UTI Medication Needed for Children

RECCE 327 fast dosing UTI medication advances in Phase 2 clinical research
UTI
Urinary Track Infection (UTI)